$2.28T
Total marketcap
$104.43B
Total volume
BTC 49.91%     ETH 15.51%
Dominance

PHC Co.,Ltd. 057880.KQ Stock

1740 KRW {{ price }} 0.000000% {{change_pct}}%
Exchange
KOSDAQ
Market Cap
205.82B KRW
LOW - HIGH [24H]
1680 - 1770 KRW
VOLUME [24H]
7.76M KRW
{{ volume }}
P/E Ratio
0
Earnings per share
0 KRW

PHC Co.,Ltd. Price Chart

PHC Co.,Ltd. 057880.KQ Financial and Trading Overview

PHC Co.,Ltd. stock price 1740 KRW
Previous Close 1740 KRW
Open 1690 KRW
Bid 1720 KRW x 0
Ask 1725 KRW x 0
Day's Range 1680 - 1770 KRW
52 Week Range 1680 - 1970 KRW
Volume 7.76M KRW
Avg. Volume 565.55K KRW
Market Cap 68.37B KRW
Beta (5Y Monthly) -0.146906
PE Ratio (TTM) N/A
EPS (TTM) 0 KRW
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

057880.KQ Valuation Measures

Enterprise Value 194.48B KRW
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 5.1408653
Price/Book (mrq) N/A
Enterprise Value/Revenue 14.624
Enterprise Value/EBITDA -5.069

Trading Information

PHC Co.,Ltd. Stock Price History

Beta (5Y Monthly) -0.146906
52-Week Change 0%
S&P500 52-Week Change 20.43%
52 Week High 1970 KRW
52 Week Low 1680 KRW
50-Day Moving Average 1935 KRW
200-Day Moving Average 1935 KRW

057880.KQ Share Statistics

Avg. Volume (3 month) 565.55K KRW
Avg. Daily Volume (10-Days) 189.2K KRW
Shares Outstanding 39.29M
Float 105.93M
Short Ratio N/A
% Held by Insiders 10.40%
% Held by Institutions 0.20%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate N/A
Trailing Annual Dividend Yield N/A
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2021
Most Recent Quarter (mrq) September 30, 2022
Next Fiscal Year End December 31, 2022

Profitability

Profit Margin 0%
Operating Margin (ttm) -296.67%
Gross Margin -7.45%
EBITDA Margin -288.49%

Management Effectiveness

Return on Assets (ttm) -22.18%
Return on Equity (ttm) -44.80%

Income Statement

Revenue (ttm) 13.3B KRW
Revenue Per Share (ttm) 112.35 KRW
Quarterly Revenue Growth (yoy) -91.29%
Gross Profit (ttm) 4.78B KRW
EBITDA -38366769152 KRW
Net Income Avi to Common (ttm) -43735334912 KRW
Diluted EPS (ttm) N/A
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 12.31B KRW
Total Cash Per Share (mrq) 104.04 KRW
Total Debt (mrq) 967.07M KRW
Total Debt/Equity (mrq) 1.36 KRW
Current Ratio (mrq) 7.285
Book Value Per Share (mrq) N/A

Cash Flow Statement

Operating Cash Flow (ttm) -17241403392 KRW
Levered Free Cash Flow (ttm) -22419499008 KRW

Profile of PHC Co.,Ltd.

Country South Korea
State N/A
City Seongnam-si
Address 23, Jungjail-ro
ZIP 463-869
Phone 82 3 1778 0800
Website https://www.philosyshealthcare.co.kr
Industry
Sector(s)
Full Time Employees 74

PHC Co.,Ltd. engages in the medical drug, bio, medical, and distribution businesses in South Korea and internationally. The company develops Nex Bio drugs for the treatment of hemophilia A, anemia, hormone, and macular degeneration diseases. It also offers various bio products, including house dust mite removers under the FromG brand name; and orthopedic biotransplant fusion medical devices. In addition, it distributes various products through domestic home shopping, data broadcasting, and B2B delivery channels. PHC Co.,Ltd. was founded in 1998 and is based in Seongnam, South Korea.

Q&A For PHC Co.,Ltd. Stock

What is a current 057880.KQ stock price?

PHC Co.,Ltd. 057880.KQ stock price today per share is 1740 KRW.

How to purchase PHC Co.,Ltd. stock?

You can buy 057880.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for PHC Co.,Ltd.?

The stock symbol or ticker of PHC Co.,Ltd. is 057880.KQ.

How many shares does PHC Co.,Ltd. have in circulation?

The max supply of PHC Co.,Ltd. shares is 118.29M.

What is PHC Co.,Ltd. Price to Earnings Ratio (PE Ratio)?

PHC Co.,Ltd. PE Ratio is now.

What was PHC Co.,Ltd. earnings per share over the trailing 12 months (TTM)?

PHC Co.,Ltd. EPS is 0 KRW over the trailing 12 months.